153 related articles for article (PubMed ID: 4524752)
1. Dysplastic platelets and circulating megakaryocytes in chronic myeloproliferative diseases. I. The platelets: ultrastructure and peroxidase reaction.
Maldonado JE; Pintado T; Pierre RV
Blood; 1974 Jun; 43(6):797-809. PubMed ID: 4524752
[No Abstract] [Full Text] [Related]
2. Platelet defects in the myeloproliferative disorders.
Inceman S; Tangün Y
Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
[No Abstract] [Full Text] [Related]
3. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
Tangün Y
Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
[No Abstract] [Full Text] [Related]
4. Megakaryocytes in cubital venous blood in patients with chronic myeloproliferative diseases.
Tinggaard Pedersen N; Laursen B
Scand J Haematol; 1983 Jan; 30(1):50-8. PubMed ID: 6573016
[TBL] [Abstract][Full Text] [Related]
5. Dysplastic platelets and circulating megakaryocytes in chronic myeloproliferative diseases. II. Ultrastructure of circulating megakaryocytes.
Maldonado JE
Blood; 1974 Jun; 43(6):811-20. PubMed ID: 4831641
[No Abstract] [Full Text] [Related]
6. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
Brodsky I; Kahn SB; Ross EM; Petkov G
Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
[No Abstract] [Full Text] [Related]
7. Platelet and fibrinogen kinetics with ( 75 Se)-selenomethionine in patients with myeloproliferative disorders.
Brodsky I; Ross EM; Petkov G; Kahn SB
Br J Haematol; 1972 Feb; 22(2):179-92. PubMed ID: 4500669
[No Abstract] [Full Text] [Related]
8. Platelet peroxidase deficiency in a case of myelodysplastic syndrome with myelofibrosis.
Imbert M; Jarry MT; Tulliez M; Breton-Gorius J
J Clin Pathol; 1983 Nov; 36(11):1223-8. PubMed ID: 6630573
[TBL] [Abstract][Full Text] [Related]
9. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
Okuma M
Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1139-44. PubMed ID: 6800179
[No Abstract] [Full Text] [Related]
10. Studies on the phagocytic activity of neutrophilic leukocytes.
Brandt L
Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
[No Abstract] [Full Text] [Related]
11. Beta-thromboglobulin content in megakaryocytes of patients with myeloproliferative diseases.
Grossi A; Vannucchi AM; Rafanelli D; Filimberti E; Rossi Ferrini P
Thromb Res; 1986 Aug; 43(3):367-74. PubMed ID: 2426823
[No Abstract] [Full Text] [Related]
12. [Chromosome findings in myeloproliferative diseases].
Hellriegel KP
Internist (Berl); 1968 Dec; 9(12):465-70. PubMed ID: 4891471
[No Abstract] [Full Text] [Related]
13. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
14. [Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].
Petrov MN; Vashkinel' VK
Probl Gematol Pereliv Krovi; 1977 May; 22(5):18-23. PubMed ID: 267283
[No Abstract] [Full Text] [Related]
15. Circulating megakaryoblasts in chronic myeloproliferative diseases. An immunoelectron-microscopic study.
Matolcsy A; Majdic O
Acta Haematol; 1990; 84(2):57-63. PubMed ID: 2120886
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
17. Platelets in the myeloproliferative syndrome.
Weinfeld A; Branehög I; Kutti J
Clin Haematol; 1975 Jun; 4(2):373-92. PubMed ID: 1102193
[No Abstract] [Full Text] [Related]
18. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
Barbui T; Battista R; Dini E
Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
[No Abstract] [Full Text] [Related]
20. Significance of circulating megakaryocytes in chronic myeloproliferative syndromes.
Hanganu E; Iordăcheanu L; Popa G
Rev Med Chir Soc Med Nat Iasi; 1983; 87(3):377-8. PubMed ID: 6587496
[No Abstract] [Full Text] [Related]
[Next] [New Search]
